Bradley L. Radoff - Aug 15, 2022 Form 4 Insider Report for HARTE HANKS INC (HHS)

Role
Director
Signature
/s/Bradley L. Radoff
Stock symbol
HHS
Transactions as of
Aug 15, 2022
Transactions value $
-$7,360,037
Form type
4
Date filed
8/17/2022, 05:35 PM
Previous filing
Jul 13, 2022
Next filing
Oct 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HHS Common stock Sale -$1.17M -77.7K -61.25% $15.12 49.1K Aug 15, 2022 Direct F1, F2
transaction HHS Common stock Sale -$43.2K -2.85K -5.79% $15.17 46.3K Aug 16, 2022 Direct F1, F3
transaction HHS Common stock Sale -$758K -50K -100% $15.17 0 Aug 16, 2022 Radoff Family Foundation F1, F3, F4
transaction HHS Common stock Sale -$5.06M -334K -64.95% $15.17 180K Aug 16, 2022 BLR Partners LP F1, F3, F5
transaction HHS Common stock Sale -$326K -20K -11.11% $16.31 160K Aug 17, 2022 BLR Partners LP F1, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the securities of the Issuer reported owned herein except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.96 to $15.545 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.01 to $15.755 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Shares of common stock beneficially owned directly by the Radoff Family Foundation. As a director of the Radoff Family Foundation, Mr. Radoff may be deemed to beneficially own the shares of common stock beneficially owned by the Radoff Family Foundation.
F5 Shares of common stock beneficially owned directly by BLR Partners LP. Mr. Radoff, as the sole shareholder and sole director of BLRGP Inc., which serves as the general partner of BLRPart LP, which serves as the general partner of BLR Partners LP, and as the sole shareholder and sole director of FLMP Inc., which serves as the general partner of Fondren Management, LP, which serves as the investment manager of BLR Partners LP, may be deemed to beneficially own the shares of Common Stock beneficially owned directly by BLR Partners LP.
F6 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.90 to $16.82 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.